FR2626470B1 - Depresseur de l'inhibiteur de l'(alpha)2-plasmine - Google Patents

Depresseur de l'inhibiteur de l'(alpha)2-plasmine

Info

Publication number
FR2626470B1
FR2626470B1 FR8816071A FR8816071A FR2626470B1 FR 2626470 B1 FR2626470 B1 FR 2626470B1 FR 8816071 A FR8816071 A FR 8816071A FR 8816071 A FR8816071 A FR 8816071A FR 2626470 B1 FR2626470 B1 FR 2626470B1
Authority
FR
France
Prior art keywords
acid addition
physiologically acceptable
acceptable acid
addition salt
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR8816071A
Other languages
English (en)
Other versions
FR2626470A1 (fr
Inventor
Yoshikuni Yoshikuki
Ojima Nobutoshi
Mori Kazuya
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Shinyaku Co Ltd
Original Assignee
Nippon Shinyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Shinyaku Co Ltd filed Critical Nippon Shinyaku Co Ltd
Publication of FR2626470A1 publication Critical patent/FR2626470A1/fr
Application granted granted Critical
Publication of FR2626470B1 publication Critical patent/FR2626470B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004Monosaccharides having only carbon, hydrogen and oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
FR8816071A 1987-12-09 1988-12-07 Depresseur de l'inhibiteur de l'(alpha)2-plasmine Expired - Fee Related FR2626470B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP31134887 1987-12-09

Publications (2)

Publication Number Publication Date
FR2626470A1 FR2626470A1 (fr) 1989-08-04
FR2626470B1 true FR2626470B1 (fr) 1994-12-09

Family

ID=18016066

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8816071A Expired - Fee Related FR2626470B1 (fr) 1987-12-09 1988-12-07 Depresseur de l'inhibiteur de l'(alpha)2-plasmine

Country Status (11)

Country Link
EP (1) EP0319986B1 (fr)
KR (1) KR960009417B1 (fr)
AT (1) ATE149836T1 (fr)
BE (1) BE1004874A4 (fr)
CA (1) CA1316831C (fr)
CH (1) CH677610A5 (fr)
DE (1) DE3855824T2 (fr)
FR (1) FR2626470B1 (fr)
GB (2) GB8827701D0 (fr)
IL (1) IL88573A (fr)
SE (1) SE502110C2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990001319A1 (fr) * 1988-08-10 1990-02-22 The Australian National University Utilisation de castanospermine comme agent anti-inflammatoire et immunosuppresseur
WO1998006264A1 (fr) * 1996-08-14 1998-02-19 Myung Hee Chun Therapie par appauvrissement de la plasmine
EP1903034A1 (fr) * 2006-09-19 2008-03-26 Technische Universität Graz Iminosucres glycoconjugués

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54106477A (en) * 1978-02-03 1979-08-21 Nippon Shinyaku Co Ltd Moranoline derivative
JPS5943946B2 (ja) * 1978-04-28 1984-10-25 日本新薬株式会社 N−アルケニルモラノリン誘導体
JPS5943947B2 (ja) * 1978-05-03 1984-10-25 日本新薬株式会社 N−置換モラノリン誘導体
GB2020278B (en) * 1978-05-03 1983-02-23 Nippon Shinyaku Co Ltd Moranoline dervitives
JPS6026387B2 (ja) * 1979-01-20 1985-06-24 日本新薬株式会社 シンナミルモラノリン誘導体
JPS5943949B2 (ja) * 1978-09-29 1984-10-25 日本新薬株式会社 モラノリンのn−置換誘導体
DE2925943A1 (de) * 1979-06-27 1981-01-29 Bayer Ag 1-alkadien-2,4-yl-2-hydroxymethyl3,4,5-trihydroxypiperidine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
JPS56108767A (en) * 1980-01-28 1981-08-28 Nippon Shinyaku Co Ltd Bismoranoline derivative
DE3007078A1 (de) * 1980-02-26 1981-09-10 Bayer Ag, 5090 Leverkusen Neue derivate von 3,4,5-trihydroxypiperidin, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel sowie in der tierernaehrung
JPS60224675A (ja) * 1984-04-24 1985-11-09 Meiji Seika Kaisha Ltd 新規1−デオキシノジリマイシン誘導体およびそれを含有する血中脂質低下剤
CA1327970C (fr) * 1985-05-24 1994-03-22 Paul S. Liu Isolement de la castanospermine et son usage comme agent antidiabetique
DE3650377T2 (de) * 1985-12-23 1996-02-22 Hutchinson Fred Cancer Res Regulierung der retroviralen replikation, infektion und pathogenese.
ZA883925B (en) * 1987-06-08 1989-02-22 Merrell Dow Pharma Inhibitors of glycoprotein processing having anti-retroviral activity

Also Published As

Publication number Publication date
GB2213374B (en) 1992-01-29
CH677610A5 (fr) 1991-06-14
EP0319986A3 (fr) 1992-09-30
BE1004874A4 (fr) 1993-02-16
KR890009399A (ko) 1989-08-01
IL88573A (en) 1994-05-30
ATE149836T1 (de) 1997-03-15
CA1316831C (fr) 1993-04-27
GB8827927D0 (en) 1989-01-05
GB8827701D0 (en) 1988-12-29
DE3855824T2 (de) 1997-10-16
SE8804436D0 (sv) 1988-12-08
KR960009417B1 (ko) 1996-07-19
FR2626470A1 (fr) 1989-08-04
SE8804436L (sv) 1989-06-10
SE502110C2 (sv) 1995-08-21
DE3855824D1 (de) 1997-04-17
EP0319986A2 (fr) 1989-06-14
GB2213374A (en) 1989-08-16
EP0319986B1 (fr) 1997-03-12

Similar Documents

Publication Publication Date Title
GR3005315T3 (fr)
PL344048A1 (en) Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
DE69012840T2 (de) Adenosin-Derivate, die eine Aktivität gegen Bluthochdruck haben.
ES8801217A1 (es) Un procedimiento para la preparacion de un derivado de acido 5-imidazolcarboxilico
HU9603185D0 (en) New azolidinediones as antihyperglycemic agents
ES8801245A1 (es) Un procedimiento para preparar derivados de piperidina
CA2103590A1 (fr) Derive benzamide
DK0888337T3 (da) Piperidon-tachykininantagonister
EA200300044A1 (ru) Новые замещенные фталиды, способ их получения и содержащие их фармацевтические композиции
FR2626470B1 (fr) Depresseur de l'inhibiteur de l'(alpha)2-plasmine
EP0335979A4 (en) Thienopyrimidine derivatives
CA2014521A1 (fr) N,n'-ditrimethoxybenzoyl piperazines substituees en position 2, procede de preparation et composes therapeutiques les contenant
CA2118425A1 (fr) Derive du benzothiazolesulfamide, son mode de preparation et son utilisation
EP0123962A3 (en) Novel benzimidazole derivative, process for the preparation thereof and pharmaceutical composition
ES8801615A1 (es) Un procedimiento para preparar esteres de acidos ciclopropanocarboxolico que contienen fluor.
ATE50248T1 (de) Ein imidazolidintrion-derivat oder ein seiner pharmazeutisch akzeptierbaren salze enthaltende pharmazeutische zusammenstellung.
GR3007219T3 (fr)
EP0414903A4 (en) New thioproline derivative
EP0376162A3 (fr) Produit inhibant la formation de plaque dentaire
WO2001035938A3 (fr) Derives tetrahydrothiopyran-4-ol pharmacologiquement actifs, leur procede de fabrication et leur utilisation
TNSN86099A1 (fr) Nouveaux benzamides, leur procede de preparation et leur application dans le domaine therapeutique
DE69219219D1 (de) Verwendung von 3-Pyridazinone zur Verringerung der Blutplätchenzahl
ATE131480T1 (de) Pyrimidoindolderivate und verfahren zu ihrer herstellung
ES8604210A1 (es) Procedimiento para preparar 2- (fenetil) -5- (3,4-metilen- dioxi)-x-hidroxibencil) -pirrolidina

Legal Events

Date Code Title Description
ST Notification of lapse